Introduction: Diabetes mellitus (DM) is a metabolic disorder characterized by abnormal carbohydrate, fat, and protein metabolism, which is clinically diagnosed based on hyperglycemia. Ayurveda has explained Avyayama (lack of exercise) as the first and foremost cause for diabetes.
INTRODUCTION
Madhumeha which has been correlated with DM has become a global problem in spite of advances in modern science. DM occurs throughout the world, but is more common (especially Type 2) in the more developed countries. The greatest increase in prevalence is, however, expected to occur in Asia and Africa, where most patients will probably be found by 2030. 1 WHO has anticipated tioning of the pancreas, which is responsible for the production of the hormone insulin and characterized by abnormal carbohydrate, fat, and protein metabolism. It is clinically diagnosed based on the accumulation of glucose in the urine and blood of the person. This condition is known as hyperglycemia. The word diabetes has been derived from two words, diabetes (Greek) which means 'siphon through' and mellitus (Latin) which means 'sweetened with honey'. Ayurveda includes diabetes mellitus under the Prameha category. Prameha is a list of urinary disorders, especially characterized by profuse urination with several abnormal qualities. There are twenty kinds of Pramehas in Ayurveda. According to the doshic causes, these Pramehas are classified as four Vataja pramehas, six Pittaja pramehas and ten Kaphaja pramehas. Out of these, DM is termed as Madhumeha which comes under Vataja prameha. 4, 5 In Ayurveda, it is also described as a Maharoga (major disease) 6 because of its multifaceted effects in the body and also every cell of the human physiology. The disease Madhumeha affects three Doshas (body humor) and all the Dhatus (tissues) except Asthi. Ayurveda has explained Avyayama (lack of exercise) as the first and foremost cause for diabetes. Daytime sleep, lack of exercise, lethargy (sedentary lifestyle), consumption of food and drinks which are cold, unctuous and sweet in taste, utilization of fatty items in excess etc., are main causative factors. 7 It can be said in a way that the Ayurvedic remedies for DM are the oldest among all the available therapies. There are so many poly-herbal and herbo-mineral formulations in Indian system of medicine having hypoglycaemic as well as anti-diabetic property. DM has gained massive disgrace in recent times as it is fast becoming the world's largest silent killer. The complications of diabetes are more dreadful than the disease itself. However, a person sticks to an Ayurvedic preventive strategy right from the beginning can easily avert this disease or control it, if already suffering.
In spite of many advances, the allopathic management of diabetes remains unsatisfactory. Insulin resistance, hypersensitivity, drug intolerance, and hypoglycemic episodes make it all the more important to search out safe, effective and cheaper drugs.
OBJECTIVES
The main objectives were to assess the clinical efficacy and clinical safety of Nisha Katakadi Kashaya and Yashada Bhasma (individually as well as in combination) in the management of Type 2 DM (Madhumeha).
MATERIALS AND METHODS

Study Design
This was an interventional, open randomized multicenter clinical study. The study protocol and related documents were reviewed and approved by the Institutional Ethics committee of each participating centre i.e. Dr 
Outcome Measures
Primary Outcome Measure of study was to evaluate clinical efficacy of Nisha Katakadi Kashaya and Yashada Bhasma (individually as well as in combination) in the management of Type 2 DM by assessing change in blood sugar fasting (10-12 hours after dinner). The Secondary outcome measures of the study were to evaluate the changes in DSQ score, change in glycosylated hemoglobin (HbA 1 c), change in blood sugar post-prandial (100-120 minutes after breakfast) and quality of life (SF-36-Health Research and Development Survey Score).
Trial Interventions
Subjects in Group I were treated with Nisha Katakadi Kashaya 8 in a dose of 15 ml (diluted with 45 ml water) twice daily before food with lukewarm water. In Group II, Capsule Yashada Bhasma 9 125 mg thrice in a day was administered with lukewarm water before food and in Group III, Nisha Katakadi Kashaya, 15 ml (to be diluted with 45 ml water) twice daily and capsule Yashada Bhasma, 125 mg thrice in a day were administered. The duration of treatment was 12 weeks (84 days) in all the groups, and the effect of the drug was assessed up to 14th week. All the drugs were procured from the good manufacturing practice (GMP) certified laboratory complying with the standards of Ayurvedic Pharmacopoeia of India (API).
Inclusion Criteria
Subjects of either sex aged between 30 to 60 years, who were diagnosed to be Type 2 DM by either having Glycosylated hemoglobin (HbA 1 c) ≥ 6.5% or fasting blood Sugar (BS-F) > 126 mg% or Post prandial blood sugar (BS-PP) > 200 mg% or diabetics who were on lifestyle modifications (on diet management and physical exercise) or subjects who were on Tablet. Metformin (up to 2 gm/ day) and who was willing to participate in the clinical trial for 14 weeks were included in the study. 
Exclusion Criteria
Withdrawal Criteria
The subjects were free to withdraw from the trial at any time without the permission of investigator or any reason. Further, the investigator could discontinue the subject if he/she develop any adverse effect such as Coronary heart disease, uncontrolled hypoglycaemia, or any other condition necessitating hospitalization or there was noncompliance of the treatment regimen (minimum 80% compliance was essential to continue in the study). In these cases, the actions were taken to know the reason for the withdrawal and recorded in the case report forms.
Laboratory Investigations
The laboratory investigations like Hb%, total leukocyte count (TLC), differential leukocyte count (DLC) eryhtrocyte segmentation rate (ESR), blood sugar fasting and postprandial, LFT, lipid profile, HbA 1 c, urine examination; radiological investigations like posterior/anterior view of chest and ECG were undertaken before and after the study. Serum Urea, Serum uric acid, Serum creatinine, SGOT, SGPT, etc., were also assessed before and after the study for clinically safety evaluation of the trial drugs.
Study Procedure
On screening visit, subject's voluntary written informed consent was taken. General and systemic examinations were done, and laboratory parameters and radiological findings were assessed. If the subject met the inclusion and exclusion criteria then enrolled in the trial. At baseline (0 days), the demographic data viz. socioeconomic status, religion, education, medical history, habit, addiction, and other personal data were collected in the case report form. Physical and systemic examinations were carried out. Clinical assessment through DSQ score (it contains 30 questions that show how often the symptoms occurred), assessment of Ayurvedic parameters, quality of life by SF-36 (RAND) Health Survey Score ( it contains 36 questions, which are related to the generic measure of health-related quality of life profiling eight dimensions covering physical and mental health, including physical functioning, limitations due to physical health, limitations due to emotional problems, energy/fatigue, emotional wellbeing, social functioning, pain, and general health) were performed. Then the trial drugs were dispensed along with the drug compliance report form with the instruction to the subject to fill it and brought back the duly filled form and empty containers on his subsequent follow-up visit.
Total 193 subjects who fulfill the inclusion and exclusion criteria were randomly selected (computer generated randomization) into three groups on 1st come 1st basis (ALRCA-56, NARIVBD-60, ARRI-60, and NRIP-17) and enrolled for the study, in three groups, i.e., in Group I Nisha Katakadi Kashaya, 15 ml (diluted with 45 ml Water) twice daily before food with lukewarm water, in Group II, capsule of Yashada Bhasma 125 mg thrice in a day were administered with lukewarm water before food and in Group III, Nisha Katakadi Kashaya, 15 ml (diluted with 45 ml water) twice daily and Capsule. Yashada Bhasma, 125 mg thrice in a day was administered for 12 weeks, assessed every 2nd week up to 14th week as per the protocol. Recruited subjects were advised to follow the Pathyaharas (wholesome diet) and exercise accordingly (i.e., regular moderate physical activity, take care to eat plenty of fibre-rich cereal products and vegetables every day). Table 1 : Demographic profile and baseline characteristics of study subjects of the subjects in three groups (n = 189) 
Follow-up Assessment
Subjects were called for follow-up visits on 14th day (Visit 1), 28th day (Visit 2), 42nd day (Visit 3), 56th day (Visit 4), and 70th day (Visit 5). On each follow-up visit, Physical examination, laboratory investigations (Blood sugar-fasting, Postprandial) were done, trial medicine (drugs) and drug compliance report form issued, the subjects were advised to return empty containers of trial medicines on every follow-up visit in order to check the drug compliance. All the laboratory investigations like biochemical, hematological parameters; radiological procedures; general physical and systemic examination were done on 84th day (Visit 6). The clinical assessment by DSQ score, assessment of Ayurvedic parameters and assessment of quality of life were carried out at the end of the treatment period, i.e., 84th day and at 98th day (without interventions) (Visit 7) for assessing the changes in said parameters and clinical safety of the trial drugs.
Statistical Analysis
The analysis of the data using statistical software statistical package for social science (SPSS) 15.0 data describing quantitative measures are expressed as median or mean ± SD or SE or the mean with range. Qualitative variables are presented as counts and percentage. Comparison of variables representing categorical data was performed using the chi-square test. All p values are reported based on a two-sided significance test and all the statistical tests are interpreted as significance at 5% level (p < 0.05).
RESULT
Total 193 subjects were enrolled in the study, out of which 178 cases were completed, and 15 cases were dropped out due to loss of follow-up. The data of 11 subjects were taken for analysis along with the data of completed cases by last observation carry forward method for intentionto-treat analysis. The demographic profile and baseline characteristics of 189 subjects are presented in Table 1 . It is observed that nearly 21% (n-40) of the study population were from the age group of 31-42 years, while 79% (n-149) were from the age group of 43-60 years. 
JRAS
YB (Group II) shows good improvement in Malina danta (Tartar in teeth), Trishna (excessive thirst), Prabhuta mutrata (excessive urination).
When compared to the baseline to end of the study, Clinical symptoms 13 like polydipsia, body ache, polyneuritis and visual disturbances are showed good improvement in Group III (NK + YB); the polyuria, exhaustion, and Giddiness are showed good improvement in Group II (YB group. The details are depicted in Table 3 .
Effect of the Drugs on DSQ Score
In all the three groups, the effect of the trial drugs on the DSQ score (it shows how often the diabetes symptoms occurred in the initial stage of the trial and after completion of the trial) was statistically highly significant on the end of the treatment, i.e., 84th day and sustained the results after the follow-up period (without any intervention), i.e., on 98th day when compare to the baseline (Table 4 , Fig. 1 ).
Effect of the Trial Drugs on Quality of Life of the Study Subjects
The efficacy of trial drugs, i.e., Nisha katakadi kashayam (Group I), Yasada Bhasma (Group II) and the combination of Nisha katakadi Kashayam and Yasada Bhasma (Group III) on subjective parameters like quality of life of the study participants were assessed by using DSQ and SF-36 (RAND) health survey score was found statistically highly significant (p < 0.001) at the end of the treatment and follow up period when compared to the baseline. SF-36 items and scales are scored so that a higher score indicates a better health state. For example, functioning scales are scored so that a high score indicates better functioning and the pain scale is scored so that a high score indicates freedom from pain. 14 The details are depicted in (Tables 5 to 7 , and Figures 2 to 4) .
Effect of the Trial Drugs on Fasting and Post Pandrial Blood Sugar in Three Groups
While analyzing the objective parameters, i.e., fasting blood sugar (FBS), postprandial blood sugar (PPBS), HbA 1 c from baseline to end of the treatment, it was experiential that, the effect of NK Group (Nisha katakadi Kashayam), YB group (Yasada Bhasma) and NK + YB group (combination of both of Nisha katakadi Kashayam and Yasada Bhasma) illustrate statistically not significant (p > 0.05) ( Tables 8 to 10 , and Figures 5 and 6) .
Further, the mean of HbA 1 c at the baseline to 84th day in Group II and Group III is showing slight improvement, but statistically not significant (Table 11) .
Effect of the Trial Drugs on Laboratory Parameters in Three Groups
There was no significant change observed in safety parameters (laboratory parameters) like renal function 
DISCUSSION
Medicinal herbs have never become obsolete and still play a prominent role in human health care. Among them, over 1200 plants have been claimed to be remedies Therefore, therapies will be directed at both Vata and Kapha simultaneously to restore the balance of the doshas. Another basic difference is in the treatment of the complications that DM causes. DM can cause several complications in the long run such as kidney failure; paralysis and gangrene etc., each of these can be fatal conditions individually. Conventional medical science tries to reduce the blood sugar level but does not put more weight on the treatment of the complications. However, in Ayurveda, Madhumeha is a broad concept which does not include just the hyperglycemia; it also takes into account all the Values are expressed as mean (standard deviation), p-value < 0.05 has been considered as significant contd... Values are expressed as mean (standard deviation), *p-value <0.05 has been considered as significant Values are expressed as mean (standard deviation), p-value < 0.05 has been considered as significant Values are expressed as mean (standard deviation), p-value < 0.05 has been considered as significant Values are expressed as mean (standard deviation), p-value < 0.05 has been considered as significant Values are expressed as mean (standard deviation), p-value < 0.05 has been considered as significant CONCLUSION DM is reaching potentially epidemic proportions in India. The level of morbidity and mortality due to diabetes and its potential complications are enormous, and pose significant healthcare burdens on families and society. Despite significant progress in Type 2 DM and the development of antidiabetic drugs, no cures have been found. 24 Medicinal herbs, long used in alternative and complementary medicine systems, are an extremely rich source of Type 2 DM remedies. Based on safety and their multiple targeting actions, herbal therapies are potent therapeutic means in Type 2 DM.
JRAS
Based on this multicentre clinical trial it is inferred that the combination of Ayurvedic formulations Nishakathakadi Kashayam in group I, Yashada Bhasma in group II and both the drugs in group III has good efficacy in the management of Type 2 DM individually and in combination. These drugs showed statistically highly significant (P < 0.001) in relieving subjective parameters like Clinical symptoms, DSQ score and Quality of life (SF 36 survey score) of the patient without altering objective parameters viz. HbA 1 c% and blood sugar levels. Hence it can be concluded that, these drugs are effective and can be used safely in the management of Type 2 DM (Madhumeha).
